Soza Tharwat Baban
College of Health Sciences
Department of Medical Microbiology
Dr. Soza Baban is a medical and molecular microbiologist with specialization in hospital-acquired infections and infection control and prevention, and Stem Cell Therapy and tissue engineering specialist.
She had awarded her PhD degree in Molecular Medical Microbiology in 2011 with distinction at the University of Nottingham, Center for Biomolecular Sciences, Institute of Infection, Immunity and Inflammation, Nottingham, UK, where she studied the virulence of the human hypervirulent UK-outbreak hospital strain of Clostridium difficile infection in UK. Before this, she successfully obtained her MSc degree in Molecular Clinical Microbiology at the University of Nottingham in 2007.
She undertook pioneering diagnostic laboratory work on the virulence of Clostridium difficile infection as part of a large programme of work funded by the UK Medical Research Council (MRC) and the European Union under the 7th European Framework Hyperdiff Clinical Program. This has resulted in two significant publications, namely;
- Baban ST, Kuehne SA, Barketi-Klai A, Cartman ST, Kelly ML, Hardie KR, Kansau I, Collignon A, Minton NP. The Role of Flagella in C. difficile Pathogenesis: Comparison between a Non-Epidemic and an Epidemic Strain. PLoS One. 2013; 8(9):e73026.
- Ðapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013; 195(3):545-55.
She additionally published her studies in numerous scientific presentation as a speaker worldwide in her field of specality at national and international congresses.
She awarded a prestigious 8 week Research Fellowship with the Federation of European Microbiology Society (FEMS) to work in the laboratory of Dept. de Microbiologie, Faculte of Pharmacie, Universite Paris de Sud in France.
She has extensive experience in the field of Stem Cell therapy and tissue engineering researches. She worked on stem cell culture and invented in vitro cell culture models of infection using human intestinal cells.
She has extensive experience of more than 8 years molecular diagnostics of infectious diseases and cell culture.
Moreover, infection prevention and control has become one of her interests as a prime concern because antimicrobial therapy is becoming ever more difficult due to increasing rate of antimicrobial resistance among common HAI pathogens in her country.
Her responsibilities were to develop infection control policies and procedures during the commissioning phase of the hospital. She implemented infection control program at these hospitals in addition to her supervision of diagnostic microbiology laboratory.
Recently she received medical fellowship from the European Society of Clinical Microbiology and Infectious diseases (ESCMID) at Septic Surgery department at Charité - University Medicine Berlin, in July 2016. She was trained on using advanced molecular techniques that aid in diagnosis of implant-associated infections.
Dr. Soza Baban's major focus on the following research fields:
- Stem Cell Therapy
- Tissue Engineering and culture
- Molecular diagnostics of infectious diseases
- Prevalence and Antibiotics Susceptibility of Streptococcus spp. Isolated from wound Infections in Erbil City.
- Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta-Lactamase-Producing Escherichia Coli Isolated from Urinary Tract Infection among Infants and Young Children in Erbil City.
- Prevalence and Antimicrobial Susceptibility of Extended Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella species Isolated from Urinary Tract Infections.
- Prevalence and Antibiotics Susceptibility of Multidrug Resistant Pseudomonas aeruginosa Isolated from Wound Infection in Erbil City.
- Prevalence and Antibiotics Susceptibility of Extended-Spectrum Beta-lactamase producing Escherichia coli and Klebsiella spp. Isolated in Urinary Tract Infection in Erbil City.
- Determination of Prevalence and Antimicrobial Susceptibility of
Staphylococcus aureus in Wound Infection.
- 1. Baban ST, Kuehne SA, Barketi-Klai A, Cartman ST, Kelly ML, Hardie KR, Kansau I, Collignon A, Minton NP. The Role of Flagella in Clostridium difficile Pathogenesis: Comparison between a Non-Epidemic and an Epidemic Strain. PLoS One. 2013; 8(9):e73026.
- 2. Ðapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013; 195(3):545-55
PhD. in Molecular Medical Microbiology, Center for Biomolecular Sciences, The University of Nottingham, United Kingdom.
MSc. in Molecular Medical Microbiology, Center for Biomolecular Sciences, The University of Nottingham, United Kingdom.
- Molecular diagnosis of infectious diseases
- Stem cell therapy and tissue engineering
- Hospital infection control and prevention
- View Private Records